Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation.

MLA

Mansfield, Carol A., et al. “Preferences for Breast Cancer Prevention among Women with a BRCA1 or BRCA2 Mutation.” Hereditary Cancer in Clinical Practice, vol. 18, no. 1, Sept. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s13053-020-00152-z.

APA

Mansfield, C. A., Metcalfe, K. A., Snyder, C., Lindeman, G. J., Posner, J., Friedman, S., Lynch, H. T., Narod, S. A., Evans, D. G., & Liede, A. (2020). Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation. Hereditary Cancer in Clinical Practice, 18(1), N.PAG. https://doi.org/10.1186/s13053-020-00152-z

Chicago

Mansfield, Carol A., Kelly A. Metcalfe, Carrie Snyder, Geoffrey J. Lindeman, Joshua Posner, Sue Friedman, Henry T. Lynch, Steven A. Narod, D. Gareth Evans, and Alexander Liede. 2020. “Preferences for Breast Cancer Prevention among Women with a BRCA1 or BRCA2 Mutation.” Hereditary Cancer in Clinical Practice 18 (1): N.PAG. doi:10.1186/s13053-020-00152-z.